Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06815263 · ClinicalTrials.gov registry record · NA

Listener Training for Improved Intelligibility of People With Parkinson's Disease

A NA study of Dysarthria, Hypokinetic, sponsored by Utah State University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT06815263 is a NA study of Dysarthria, Hypokinetic that is actively recruiting participants, run by Utah State University. The registered enrollment target is 360 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06815263, a NA study of Dysarthria, Hypokinetic, is actively recruiting participants, sponsored by Utah State University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners. This translational work will establish a new realm of clinical practice in which the intelligibility impairments in PD are addressed by training partners to better understand dysarthric speech, thus elevating communication outcomes and participation in daily life.

Conditions Studied

Interventions

  • BEHAVIORAL Listener Training

Study Locations (2)

Florida

  • Florida State University - Tallahassee

Utah

  • Utah State University - Logan

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2025-03-26
Est. Completion 2029-05
Phase NA

Sponsor

Utah State University

27 total trials

What the Registry Record Tells You About NCT06815263

The ClinicalTrials.gov registry entry for NCT06815263 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dysarthria, Hypokinetic appearing as the primary indexed condition, and to 1 intervention - of which Listener Training is the first listed.

NCT06815263 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Utah.

Frequently Asked Questions

What is clinical trial NCT06815263 about?

NCT06815263 is a clinical study titled "Listener Training for Improved Intelligibility of People With Parkinson's Disease". Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to estab...

What is the current status of trial NCT06815263?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-03-26. Estimated completion is 2029-05.

What conditions does trial NCT06815263 study?

This clinical trial studies the following conditions: Dysarthria, Hypokinetic.

What interventions are being tested in trial NCT06815263?

The interventions under investigation include: Listener Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06815263?

This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06815263 being conducted?

This trial has 2 study locations across Florida, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.